ダウンロード数: 287
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.bmcl.2015.04.072.pdf | 529.77 kB | Adobe PDF | 見る/開く |
タイトル: | Magnetic resonance imaging of tumor with a self-traceable polymer conjugated with an antibody fragment. |
著者: | Yamada, Hisatsugu Hasegawa, Yoshinori Suzuki, Yuki Imai, Hirohiko https://orcid.org/0000-0002-6957-0031 (unconfirmed) Matsuda, Tetsuya https://orcid.org/0000-0002-2339-1521 (unconfirmed) Kimura, Yu https://orcid.org/0000-0001-5318-9255 (unconfirmed) Toshimitsu, Akio Aoyama, Yasuhiro Kondo, Teruyuki |
著者名の別形: | 近藤, 輝幸 |
キーワード: | Tumor imaging MRI Self-traceable polymer Anti-Her2 antibody Active targeting |
発行日: | 1-Jul-2015 |
出版者: | Elsevier Ltd. |
誌名: | Bioorganic & medicinal chemistry letters |
巻: | 25 |
号: | 13 |
開始ページ: | 2675 |
終了ページ: | 2678 |
抄録: | A (13)C-enriched phosphorylcholine polymer ((13)C-PMPC) as a self-traceable MR (magnetic resonance) tag was conjugated with a fragment (scFv) of Herceptin, a clinical antibody against antigen Her2. When injected in model mice bearing Her2(+) (gastric) and Her2(-) (pancreatic) tumors, the antibody-tag conjugate (13)C-PMPC-scFv selectively accumulated in the Her2(+) tumor with a rapid build-up/decay (accumulation/clearance) profile and, with the use of the (1)H-(13)C double-resonance (heteronuclear correlation) technique, the Her2(+) gastric tumor was clearly MR imaged. |
著作権等: | © 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ The full-text file will be made open to the public on 1 July 2017 in accordance with publisher's 'Terms and Conditions for Self-Archiving'. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 This is not the published version. Please cite only the published version. |
URI: | http://hdl.handle.net/2433/201953 |
DOI(出版社版): | 10.1016/j.bmcl.2015.04.072 |
PubMed ID: | 25958246 |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。